He also claimed that there is a signal for increased rates of clinical depression— look, I don’t to keep saying he is just flat out wrong, but it’s hard to draw any other conclusion here. https://t.co/M3TAuFYnGX https://t.co/w8y0Lkzadr https://t.co/NbS
The use of GLP-1 RA in Taiwan #T2D Reduced diagnoses of anxiety and depression in real world data @FrontiersIn https://t.co/e3spfUG59n
New Research: Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study https://t.co/ptd53TWPcW #pharmacology